Skip to main content

Table 2 Patients' summary score distribution (treatment response distribution) according to the biomarker pattern observed during the treatment time-course.

From: Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

Pattern MR SD P MDT
Continuously decline 11 2 3 1
Rise and fall 2 6 6 3
  1. MR: Measurable Response; SD: Stable Disease; P: Progression; MDT: Mortality during treatment